Skip to main content
. 2021 Jan 12;11:543. doi: 10.1038/s41598-020-80748-6

Figure 4.

Figure 4

Western blot analysis of NLRP3 inflammasome activation in bone marrow-derived macrophages (BMDMs) and dendritic cells (BMDCs). Both types of cells were treated with LPS (1 μg/ml) and ATP (5 μM), and the changes with or without fucoxanthin (40 μM) pre-treatment 4 h ago were compared. (A,B) Expression levels of the mature form of IL-1β and proteolytically processed caspase-1 in the culture media of BMDMs (A) and BMDCs (B). (C,D) Western blot analysis of NLRP3 inflammasome component expression in LPS/ATP treated BMDMs (C) and BMDCs (D) with or without fucoxanthin. (E,F) ASC oligomerization in cross-linked pellet of BMDMs (E) and BMDCs (F) was also analyzed by immunoblot.